Search | IOVS | ARVO Journals

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Registry and Natural History Study to Evaluate Clinical Non-Central Geographic Atrophy (GA) Who are CarRIers of High-Risk GeneTic Variants Associated with Age-Related Macular Degeneration (CLARITY): Study Outline and Available Baseline Data

William Bridges; Nancy Holekamp; Stephen Couvillion; Raj Maturi; Jared S Nielsen; Dante Joseph Pieramici; Glenn J Jaffe; KD Nguyen; Renta Hutabarat; Stephen Eckert; Richard MacKenna; Kiran Patki; Alia Rashid; Johanna M Seddon; Sandra Rojas-Caro

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1043. doi:

ARVO Annual Meeting Abstract April 2014

Outer Band Reflectivity Changes on SD-OCT Following Intravitreal Ocriplasmin for Vitreomacular Traction (VMT) and macular holes (MH)

Nathan C Steinle; Carlos Quezada; Ma Nasir; Dante Joseph Pieramici; Alessandro Castellarin; Robert F See; Stephen Couvillion; Dilsher Dhoot; Melvin Rabena; Robert L Avery; California Retina Consultants

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):296. doi:

ARVO Annual Meeting Abstract April 2014

Systemic Pharmacokinetics Following Intravitreal Injections of Ranibizumab, Bevacizumab or Aflibercept in Patients with DME

Robert L Avery; Alessandro Castellarin; Nathan Steinle; Dilsher Dhoot; Dante Joseph Pieramici; Robert F See; Stephen Couvillion; Ma Nasir; Kha Le; Jennifer Visich

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):586. doi:

ARVO Annual Meeting Abstract March 2012

0.5 Mg Versus 2.0 Mg Ranibizumab For Macular Edema Due To CRVO

Melvin Rabena; Dante Pieramici; Ma'an Nasir; Alessandro Castellarin; Robert See; Stephen Couvillion; Nathan Steinle; Robert Avery

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):952. doi:

ARVO Annual Meeting Abstract April 2011

Ranibizumab for Macular Edema Secondary to Perfused Central Retinal Vein Occlusion- Three Year Study

Robert L. Avery; Dante Pieramici; Ma'an Nasir; Alessandro Castellarin; Robert See; Stephen Couvillion; Melvin Rabena; Jessica Basefsky

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3967. doi:

Advertisement